THE QUESTION OF EFFICACY AND TOLERANCE DEVELOPMENT IN A LONG-TERM TREATMENT WITH DELAYED-ACTION ISOSORBIDE DINITRATE OR ISOSORBIDE-5-MONONITRATE IN HEART-DISEASE

被引：0
|
作者：
RENNHAK, U [1 ]
RIEBESEL, T [1 ]
BIAMINO, G [1 ]
机构：
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,KARDIOPULMOL ABT,D-1000 BERLIN 45,FED REP GER
来源：
ZEITSCHRIFT FUR KARDIOLOGIE | 1985年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [31] SHORT-TERM EVALUATION OF ISOSORBIDE-5-MONONITRATE SUSTAINED-RELEASE IN CHRONIC CORONARY HEART-DISEASE AND STABLE EXERTIONAL ANGINA
    MAZZOLA, C
    GUFFANTI, EE
    COLNAGO, R
    MAGGI, GC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (06): : 915 - 922
  • [32] ABRUPT WITHDRAWAL OF ISOSORBIDE-5-MONONITRATE IN DURULES (IMDUR) AFTER LONG-TERM TREATMENT IN PATIENTS WITH STABLE ANGINA-PECTORIS
    REHNQVIST, N
    OLSSON, G
    ENGVALL, J
    ROSENQVIST, U
    NYBERG, G
    ABERG, A
    ULVENSTAM, G
    UUSITALO, A
    KEYRILAINEN, O
    REINIKAINEN, P
    HARKONEN, R
    NILSSON, B
    EUROPEAN HEART JOURNAL, 1988, 9 (12) : 1339 - 1347
  • [33] PROPRANOLOL PLUS ISOSORBIDE-5-MONONITRATE FOR PORTAL-HYPERTENSION IN CIRRHOSIS - LONG-TERM HEMODYNAMIC AND RENAL EFFECTS
    MORILLAS, RM
    PLANAS, R
    CABRE, E
    GALAN, A
    QUER, JC
    FEU, F
    PAGAN, JCG
    BOSCH, J
    GASSULL, MA
    HEPATOLOGY, 1994, 20 (06) : 1502 - 1508
  • [34] EXPERIENCE OF LONG-TERM TREATMENT AND DIFFERENT DOSAGE REGIMENS OF ISOSORBIDE 5-MONONITRATE
    MEFFERT, M
    PAECKELMANN, IM
    DRUGS, 1987, 33 : 104 - 110
  • [35] Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: Interplay with sympathetic activity
    Longobardi, G
    Ferrara, N
    Leosco, D
    Abete, P
    Iannuzzi, GL
    Acanfora, D
    Furgi, G
    Nicolino, A
    Pinna, G
    Rengo, F
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (01) : 50 - 55
  • [36] Clinical evaluation of efficacy of a sustained-release preparation of isosorbide-5-mononitrate in patients with chronic ischemic heart disease
    Pushin, YM
    Nikolaeva, EP
    Churina, SK
    Churin, VD
    Nedoshivin, AO
    KARDIOLOGIYA, 1999, 39 (02) : 45 - 48
  • [37] CORRELATION OF THE PHARMACOKINETICS, PHARMACODYNAMICS AND OF THE NEUROHUMORAL SYSTEM AFTER ADMINISTRATION OF 60 MG ISOSORBIDE-5-MONONITRATE IN PATIENTS WITH CORONARY HEART-DISEASE
    MITROVIC, V
    HAIN, P
    BAHAWAR, H
    KORNECKI, P
    VOLZ, M
    GESSNER, C
    SCHLEPPER, M
    HERZ KREISLAUF, 1988, 20 (11): : 466 - 474
  • [38] LONG-TERM TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE WITH ORAL ISOSORBIDE DINITRATE AND PHENOTOLINE
    LEMKE, R
    LIPPOK, R
    KALTENBACH, M
    BUSSMANN, WD
    ZEITSCHRIFT FUR KARDIOLOGIE, 1979, 68 (02): : 82 - 88
  • [39] Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease
    Lai, Jiangtao
    Wu, Bifeng
    Sun, Jian
    Shang, Yunpeng
    Zhu, Jianhua
    CORONARY ARTERY DISEASE, 2013, 24 (07) : 566 - 571
  • [40] EFFECTS OF LONG-TERM MOLSIDOMINE TREATMENT VERSUS ISOSORBIDE DINITRATE AND PLACEBO ON EXERCISE TOLERANCE IN STABLE ANGINA
    ROMANO, M
    DECAPRIO, L
    MECCARIELLO, P
    CUOMO, S
    BALDINI, F
    DASCIA, C
    STEINBERG, G
    CHIARIELLO, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1984, 22 (05) : 246 - 249
12345